Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Azosemide"'
Autor:
Shohei Imaeda, Yasuyuki Shiraishi, Shun Kohsaka, Nozomi Niimi, Ayumi Goda, Yuji Nagatomo, Makoto Takei, Mike Saji, Shintaro Nakano, Takashi Kohno, Keiichi Fukuda, Tsutomu Yoshikawa
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2967-2977 (2022)
Abstract Aims Furosemide, a short‐acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice. However, accumulating data suggests that long‐acting loop diuretics (LD), such as torsemide or azosemide, m
Externí odkaz:
https://doaj.org/article/6957e1fa623a44feac8d31b81c5f0f56
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 22, Iss 1 (2019)
Purpose: We aimed to comprehensively evaluate the curative effect of torasemide, tolvaptan, furosemide and azosemide on patients with heart failure. Methods: Relevant studies were retrieved by searching the electronic databases until May 2018. Qualit
Autor:
Ryo Watanabe, Shichiro Abe, Shu Inami, Tomoaki Kanaya, Masashi Sakuma, Teruo Inoue, Takuo Arikawa, Shigeru Toyoda, Riichi Nishikawa, Fumiya Saito
Publikováno v:
Journal of Cardiovascular Pharmacology. 73:365-372
A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide. However, the therapeutic advantages of azosemide over furosemide have not bee
Publikováno v:
Heart Failure Reviews. 24:461-472
The majority of patients with chronic heart failure (HF) receive long-term treatment with loop diuretics. The comparative effectiveness of different loop diuretics is unknown. We searched PubMed, clinicaltrials.gov , the Cochrane Central Register of
Autor:
Yusuke Kanzaki, Hirohiko Motoki, Sho Suzuki, Takuya Maruyama, Kumiko Yahikozawa, Ayako Kozuka, Koichiro Kuwahara, Naoto Hashizume
Publikováno v:
Circulation Reports
Background: Clinical evidence of the effects of loop diuretics in patients with heart failure with preserved ejection fraction (HFpEF) is lacking. Thus, we compared the impact of azosemide and furosemide, long- and short-acting loop diuretics, in pat
Publikováno v:
BMC Chemistry, Vol 15, Iss 1, Pp 1-9 (2021)
BMC Chemistry
BMC Chemistry
BackgroundLoop diuretics are commonly used in clinical practice to manage high fluid loads and to control fluid balance. In this paper, a novel quantitative analysis method for multiple components with a single marker (QAMS) was developed for the sim
Autor:
Birthe Gericke, Björn Gailus, Marie Johne, Wolfgang Löscher, Philip Hampel, Kerstin Römermann, Edith Kaczmarek
Publikováno v:
Neuropharmacology. 185
The sodium-potassium-chloride (Na-K-Cl) cotransporter NKCC1 is found in the plasma membrane of a wide variety of cell types, including neurons, glia and endothelial cells in the brain. Increased expression of neuronal NKCC1 has been implicated in sev
Autor:
Shuji Joho, Tadakazu Hirai, Masaki Nakagaito, Makiko Nakamura, Ryuichi Ushijima, Koichiro Kinugawa
Publikováno v:
International Heart Journal. 58:978-981
Patients with stage D heart failure (HF) frequently become dependent on high doses of diuretics and inotropic agents. Recently, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), an oral antidiabetic agent, has been demonstrated to have favorable e